Implantable electrode pouch

• US 5,090,422 A
• Filed: 04/19/1990
• Issued: 02/25/1992
• Est. Priority Date: 04/19/1990
• Status: Expired due to Term

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Beatty, Graydon E., Swanson, David K., Dahl, Roger W., Heil, John E.
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): Getzow, Scott M.
• Application Number:
  US07/511,068
• Time in Patent Office: 677 Days
• Field of Search: 128/639, 128/640, 128/642, 128/784
• US Class Current: 607/119
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems
• CPC Class Codes: A61N 1/0587 Epicardial electrode systems; Endocardial electrodes piercing the pericardium

Abstract

A novel method and apparatus for isolating and anchoring an implantable electrically stimulating probe such as a defibrillator patch electrode for use with an automatic cardioverter/defibrillator is disclosed in which a porous bio-compatible coating or enclosure covers and isolates the electrode in a way which allows electrical conductivity via bodily fluid which passes through but separates the electrode from the adjacent tissue in the manner of dissection plane which substantially prevents tissue ingrowth. The coating or enclosure controls the minimum separation distance from the closest tissue and which reduces the local current density applied to adjacent tissue when the electrode is pulsed. The system includes a provision for attaching the enclosure means to internal bodily tissue.

Claims

1. In an automatic implantable cardioverter/defibrillator (AICD) system for delivering electrical shocks to the heart of a patient to restore normal cardiac rhythm, the system including an electrical input pulse generating means for generating an electrical pulse in cooperation with at least two implantable electrodes including an endocardial electrode electrically connected to said pulse generating means adapted to be positioned in the right ventricle of the heart of the patient, and a patch electrode electrically connected to said pulse generating means, said patch electrode being adapted to be positioned juxtaposed to the outside of the left ventricle of the heart, the improvement comprising:

porous bio-compatible enclosure means for isolating said patch electrode in a manner which allows electrical conduction but spaces the patch electrode from the heart tissue so as to achieve a dissection plane, said enclosure means having a thickness which defines a tissue-electrode spacing that reduces proximate tissue damage from high localized current densities, said closure means being further adapted to be fixed in position relative to proximate tissue to thereby positively position said patch electrode in the desired position with respect to the heart; and

fixation means for attaching said enclosure means proximate to the heart.

2. The automatic implantable cardioverter/defibrillator system of claim 1 wherein said porous bio-compatible enclosure means further comprises a porous polymer membrane pouch including pouch closure means, said pouch having sufficient porosity to allow passage of bodily fluid which promotes electrical conduction, but wherein the average outer pore size is small enough to minimize tissue ingrowth.

3. The automatic implantable cardioverter/defibrillator system of claim 2 wherein said fixation means further comprises a plurality of bio-compatible post members fixed to the outside of said enclosure means and adapted to cooperate with retainers selected from snap and clip members in a manner which fixes said enclosure means to the proximate tissue by trapping it between said post and the selected snap or clip retainer member.

4. The automatic implantable cardioverter/defibrillator system of claim 1 where the outer pore size is less than or equal to 20 microns.

5. The automatic implantable cardioverter/defibrillator system of claim 4 wherein the thickness of said enclosure means is between about 10 mils and 100 mils.

6. The automatic implantable cardioverter/defibrillator system of claim 1 wherein said fixation means comprises post and retainer arrangements.

7. The automatic implantable cardioverter/defibrillator system of claim 1 further comprising a coating of a porous biocompatible material covering said endocardial electrode, said coating being of sufficient porosity to allow ingress of bodily fluids to enable electrical conduction through said enclosure, said coating having a thickness which defines the tissue-electrode spacing required to reduce the localized correct density of the generated pulse applied to the tissue to a desired atraumatic level, said coating further being of a soft, resilient non-abrasive material reducing the effect of repeated impact and rubbing between said endocardial electrode and the heart tissue.

8. The automatic implantable cardioverter/defibrillator system of claim 7 further comprising an amount of medication immobilized in at least one of said enclosure means and said coating material.

9. The automatic implantable cardioverter/defibrillator of claim 7 wherein said enclosure means and coating material are polyurethane.

10. The automatic implantable cardioverter/defibrillator system of claim 9 wherein the outer pore size of said polyurethane material is less than or equal to 20 microns and the thickness is from about 10 to 100 mils.

11. The automatic implantable cardioverter/defibrillator system of claim 1 wherein said porous bio-compatable enclosure means is a multi-layer composite.

12. A means for isolating an implantable electrically active probe including an electrode means of desired configuration and an insulated conductor attached to said electrode means for chronic tissue contact comprising:

covering means for isolating said probe in a manner which substantially covers the probe except for said conductor, said covering means substantially consisting of a porous, bio-compatible material which allows infiltration of bodily fluids to provide a conductive path from said electrode member to the adjacent tissue yet has a thickness that determines the minimum spacing of said probe from direct contact with adjacent tissue and substantially isolates said electrode member from ingrowth of tissue in the manner of a dissection plane.

13. The apparatus of claim 12 wherein said porous biocompatible material has an average outer pore size less than or equal to 20 microns.

14. The apparatus of claim 12 wherein said covering means has a thickness of from about 10 mils to 100 mils.

15. The apparatus of claim 12 wherein said covering means further comprises a porous coating.

16. The apparatus of claim 15 wherein said porous biocompatible compatible material is of a non-abrasive texture and has a soft resiliency which reduces irritation to adjacent tissue due to repeated tissue impact and rubbing.

17. The apparatus of claim 12 wherein said porous biocompatible compatible material is an enclosing pouch.

18. The apparatus of claim 17 wherein said pouch consists essentially of polyurethane foam which has an outer average pore size less than or equal to 20 microns and is of a thickness of from 10 mils to 100 mils.

19. The apparatus of claim 18 wherein said porous biocompatible compatible material has a composite structure.

20. The apparatus of claim 12 further comprising an amount of immobilized medication in or beneath said covering means.

21. A means for isolating implantable devices of desired configuration associated with an electrically active probe including insulating conductor lead devices attached to an electrode member for chronic tissue contact comprising:

covering means for isolating the device in a manner which substantially covers the desired parts of a device, said covering means substantially consisting of a porous, biocompatible material which allows a degree of infiltration of bodily fluids to provide a conductive path including the electrode member which substantially isolates the covered part of the device from ingrowth of tissue in the manner of a dissection plane.

22. The apparatus of claim 21 wherein said porous biocompatible material has an average outer pore size less than or equal to 20 microns.

23. The apparatus of claim 22 wherein said covering means has a thickness of from about 10 mils to 100 mils.

24. The apparatus of claim 23 wherein said covering means further comprises a porous coating.

25. The apparatus of claim 21 wherein said porous biocompatible material is a shaped enclosed pouch.

26. The apparatus of claim 25 wherein said pouch consists essentially of polyurethane foam which has an outer average pore size less than or equal to 20 microns and is of a thickness of from 10 mils to 100 mils.

27. The apparatus of claim 26 wherein said porous biocompatible material has a composite structure.

28. The apparatus of claim 26 further comprising an amount of immobilized medication in or beneath said covering means.

29. A method of isolating an implantable electrically conductive device in juxtaposed relation to internal tissue of a patient comprising the steps of:

isolating the device by enveloping it in a flexible porous membrane said membrane being characterized by pores which are sufficiently permeable to body fluids at the site of installation such that the desired electrical conduction is established across said porous membrane via said bodily fluids but which pores are small enough to achieve a dissection plane.

30. The method of claim 29 wherein the electrically conductive device is an electrical stimulator device and comprising the further step of adjusting the thickness of the membrane to achieve the desired current density at the interface with the adjacent tissue at the maximum electrical stimulation of the device.

31. The method of claim 30 including the step of including an amount of immobilized medication beneath said membrane.

32. A method of installing an implantable electrically active probe in juxtaposed relation to internal tissue of a patient comprising the steps of:

providing a flexible porous membrane pouch for isolating the electrically active portion of the probe, said pouch being characterized by pores which are sufficiently permeable to body fluids such that the desired electrical conduction is established across said porous membrane via said bodily fluids but which pores are small enough to form a dissection plane to substantially prevent tissue ingrowth;

installing said pouch in place by fixing said pouch to tissue juxtaposed the desired probe location; and

installing the electrically active probe by insertion into said pouch.

33. The method of claim 32 wherein said pouch is fixed in place by using a post and retainer arrangement in which the body tissue to which the pouch is to be attached is trapped between post members attached to the pouch and retainer members.

34. The method of claim 32 wherein said probe is inserted in a configuration other than that of its final disposition.